It is worth noting that studies have shown that CSF levels of TNF-α in patients with MSA were significantly higher than those in PD or HCs, regardless of the duration and subtype (MSA-P or MSA-C) (Starhof et al., 2018; Compta et al., 2019). This evidence concerns the gene TNF and Parkinson disease.